Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Reuters: Company News
March 29, 2013 at 15:25 PM EDT
U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin
March 29 (Reuters) - U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States.
Read More >>
BANCO SANTANDER S.A.
Johnson & Johnson
Lexicon Pharmaceuticals, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here